Inventiva S.A. (IVA) Analyst/Investor Day Transcript
Source: SeekingAlpha
2025-10-08 19:16:38 ET
Inventiva S.A. (IVA) Analyst/Investor Day October 8, 2025 11:30 AM EDT
Company Participants
Mark Pruzanski
Andrew Obenshain - CEO & Director
Jason Campagna - President of Research and Development & Chief Medical Officer
Martine Zimmermann - Executive VP of Regulatory Affairs & Quality Assurance
...
Read the full article on Seeking Alpha
For further details see:
Inventiva S.A. (IVA) Analyst/Investor Day Transcript
Inventiva S.A.
NASDAQ: IVA
IVA Trading
3.86% G/L:
$6.60 Last:
160,600 Volume:
$6.32 Open:
IVA Latest News
IVA Stock Data
$596,933,320
80,739,058
N/A
18
N/A
Biotechnology & Life Sciences
Healthcare
FR
Daix
